Skip to content

A clinical study of a precise hydration treatment plan based on the MC-780MA body composition analyzer to prevent contrast-induced acute kidney injury in high-risk populations

A clinical study of a precise hydration treatment plan based on the MC-780MA body composition analyzer to prevent contrast-induced acute kidney injury in high-risk populations

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047565
Enrollment
Unknown
Registered
2021-06-20
Start date
2021-08-01
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

contrast-induced acute kidney injury

Interventions

Experimental group:Intensive hydration treatment regimen
Control group:General hydration regimen

Sponsors

Zhongda Hospital of Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate in this trial and sign the informed consent; 2. Aged 18 to 85 years; 3. Proposed coronary intervention; 4. AGEF score>1.16; 5. No related contraindications.

Exclusion criteria

Exclusion criteria: 1. There is a history of contrast agent allergy; 2. Lactation, pregnancy; 3. Existing or suspected acute kidney injury; 4. Those who used contrast agents and nephrotoxic drugs within 1 week before enrollment; 5. Severe renal insufficiency requiring hemodialysis; 6. Use of aortic balloon counterpulsation, acute heart failure, liver failure, connective tissue disease, tumor, serious infectious disease, cardiogenic shock in hospital, sudden cardiac death, etc.

Design outcomes

Primary

MeasureTime frame
Contrast nephropathy incidence;

Secondary

MeasureTime frame
Adverse events in postoperative hospitalization;Actual or percent (%) changes in serum creatinine, eGFR, sodium, and brain natriuretic peptide;

Countries

China

Contacts

Public ContactYan Gaoliang

Zhongda Hospital of Southeast University

yanshipingguo@163.com+86 18761890380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026